Abstract:BackgroundPortal hypertension is a key complication of portal hypertension, which is responsible for the development of varices, ascites, bleeding, and hepatic encephalopathy, which, in turn, cause a high mortality and requirement for liver transplantation.AimThis review deals with the present day state-of-the-art preventative treatments of portal hypertension in cirrhosis according to disease stage. Two main disease stages are considered, compensated and decompensated cirrhosis, the first having good prognosis and being mostly asymptomatic, and the second being heralded by the appearance of bleeding or non-bleeding complications of portal hypertension.ResultsThe aim of treatment in compensated cirrhosis is preventing clinical decompensation, the more frequent event being ascites, followed by variceal bleeding and hepatic encephalopathy. Complications are mainly driven by an increase of hepatic vein pressure gradient (HVPG) to values ≥10 mmHg (defining the presence of Clinically Significant Portal Hypertension, CSPH). Before CSPH, the treatment is limited to etiologic treatment of cirrhosis and healthy life style (abstain from alcohol, avoid/correct obesity…). When CSPH is present, association of a non-selective beta-blocker (NSBB), including carvedilol should be considered. NSBBs are mandatory if moderate/large varices are present. Patients should also enter a screening program for hepatocellular carcinoma. In decompensated patients, the goal is to prevent further bleeding if the only manifestation of decompensation was a bleeding episode, but to prevent liver transplantation and death in the common scenario where patients have manifested first non-bleeding complications. Treatment is based on the same principles (healthy life style..) associated with administration of NSBBs in combination if possible with endoscopic band ligation if there has been variceal bleeding, and complemented with simvastatin administration (20-40 mg per day in Child–Pugh A/B, 10–20 mg in Child C). Recurrence shall be treated with TIPS. TIPS might be indicated earlier in patients with: 1) Difficult/refractory ascites, who are not the best candidates for NSBBs, 2) patients having bleed under NSBBs or showing no HVPG response (decrease in HVPG of at least 20% of baseline or to values equal or below 12 mmHg). Decompensated patients shall all be considered as potential candidates for liver transplantation.ConclusionTreatment of portal hypertension has markedly improved in recent years. The present day therapy is based on accurate risk stratification according to disease stage.

Individualized treatment of pancreatic portal hypertension

Diagnosis and Management of Gastrointestinal Bleeding Caused by Pancreatic Sinistral Portal Hypertension

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

[Laparoscopic Splenectomy and Pericardial Devascularization for Treatment of Portal Hypertension Due to Liver Cirrhosis].

Surgical Treatment of Portal Vein Cavernous Transformation

Separate control of the splenic artery and vein in laparoscopic splenectomy and pericardial devascularization for the treatment of portal hypertension

Modified Laparoscopic Splenectomy Plus Pericardial Devascularization for the Treatment of Portal Hypertension

Clinical Analysis of Sinistral Portal Hypertension

The portal hypertension syndrome: etiology, classification, relevance, and animal models

Diagnosis and Treatment of Upper Gastrointestinal Hemorrhage Caused by Pancreatic Segmental Portal Hypertension

Management of Sinistral Portal Hypertension after Pancreaticoduodenectomy

Acute Pancreatitis Associated Left-Sided Portal Hypertension with Severe Gastrointestinal Bleeding Treated by Transcatheter Splenic Artery Embolization: a Case Report and Literature Review

Endoscopic treatment of portal hypertension: current status and future prospects

Clinical Application of Gastroesophageal Varices Embolization Combined with Partial Splenic Embolization in Portal Hypertension

Combined transhepatic and transsplenic recanalization of chronic splenic vein occlusion to treat left-sided portal hypertension: A cases report

Reasonable choice of surgical procedures for patients with portal hypertension

Splenectomy And Selectively Devascularization For Esophageal Bleeding Secondary To Portal Hypertension

Splenic Artery Embolization for the Treatment of Pancreatic Portal Hypertension Complicated by Gastric Variceal Haemorrhage

Periesophagogastric devascularization without splenectomy in the treatment of portal hypertension

Endovascular Management of Sinistral Portal Hypertension-Related Variceal Hemorrhage: a Multicenter Retrospective Study.

Two Surgical Procedures for Esophagogastric Variceal Bleeding in Patients with Portal Hypertension